Clinical Trial Update: Bioequivalence Study of Empagliflozin Tablet in Healthy Participants. [NA]

View source ↗

Summary

This clinical trial update reports the completion of a bioequivalence study of empagliflozin tablets in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes | NA | Status: COMPLETED